Novavax Starts Phase 2 Coronavirus Vaccine Trial, Expects Interim Readout In Q4
August 24, 2020 at 14:31 PM EDT
Novavax, Inc. has announced another milestone event in the development of its coronavirus vaccine, codenamed NVX-CoV2373.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.